On the question of non-medical cognitive enhancers among in-school adolescents: prevalence, predictors and potential health-related harms.

International Journal of Adolescent Medicine and Health
Eric JanssenJalpa Shah

Abstract

Little is known about the use of non-medical cognitive enhancers (NCEs) in the general population, and even less among youth. The study utilises a nationally representative, cross-sectional survey of adolescents attending high schools to provide a comprehensive overview of NCEs and to assess risk factors such as socio-demographics, schooling, mental health and related substance use among French adolescents. A total of 6692 students attending high school (secondary schools) answered an anonymous questionnaire collecting information on demographics, health, psychoactive substance uses (neuroleptics, tobacco, alcohol, cannabis, illicit substances) and patterns of sociability. The use of cognitive enhancers appears to be an underestimated phenomenon among youth. Prevalence of use is heavily gender-influenced, with females twice as likely to use NCEs than males. More than daily school commitments, the use of cognitive enhancers is related to the proximity of the national secondary education examination. Moreover, mental health, use of prescribed anxiolytics and other psychoactive substances are significantly independently associated with the use of cognitive enhancers, particularly among females. The unregulated use of cognitive enh...Continue Reading

References

Feb 1, 1996·Journal of Epidemiology and Community Health·D J GunnellT J Peters
Oct 19, 2000·Social Science & Medicine·T BarnettV Steshenko
Apr 28, 2001·Clinical Child and Family Psychology Review·T J Dishion, R J McMahon
Apr 22, 2004·Nature Reviews. Neuroscience·Martha J FarahPaul Root Wolpe
May 16, 2006·Pharmacoepidemiology and Drug Safety·Julien ManciniJoëlle Micallef
Dec 5, 2006·Pediatrics·Carol J BoydAmy Young
Jan 16, 2007·BMC Psychiatry·Anne Revah-LevyBruno Falissard
Mar 8, 2007·Journal of the American Geriatrics Society·Jean-François DartiguesBabak Khoshnood
Dec 23, 2009·Substance Use & Misuse·Alan D DeSantis, Audrey Curtis Hane
Dec 8, 2010·Journal of Veterinary Medical Education·Erik H HofmeisterSusan M Elrod
Oct 10, 2012·Archives of Pediatrics & Adolescent Medicine·Holly B ShakyaJames H Fowler
Apr 19, 2013·Journal of General Internal Medicine·Robyn M EmanuelCathy J Lazarus
Dec 18, 2013·Pharmacological Reviews·Suzanne WoodStephan G Anagnostaras
Oct 24, 2014·Journal of Quantitative Criminology·Abigail A FaganThomas Jaki
Mar 6, 2015·Frontiers in Systems Neuroscience·Kimberly J SchelleAnke C C M van Mil
Aug 5, 2016·BMC Psychiatry·Scott P NovakSajan Varughese
Sep 23, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Noor Azuin SulimanRusliza Basir

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Cannabis & Cognition

The effect of cannabis on cognitive functioning is being explored for short and long-term effects. Recent studies have shown conflicting results, with some showing no significant effects and others showing neuropsychological impairment. Discover the latest research on cannabis and cognition here.